S&P Global Ratings said revenue from President Donald Trump’s tariff program likely would offset some of the deficit ...

Home Depot reported weaker-than-expected quarterly earnings and sales, signaling there still hasn’t been a full-on rebound ...

Spain still faces "difficult hours" ahead in its fight against wildfires that have ravaged a record area of land, Prime ...

South African police said they arrested Tuesday the former owner of the world's largest rhino conservation farm on charges of ...

The Federal Reserve’s Michelle Bowman is urging regulators to leave their “overly cautious mind-set” on cryptocurrency, ...

As the summer doldrums set in, highflying sectors like technology may finally be due for a breather. The healthcare sector ...

Fintechs are selling off during a sleepy week on Wall Street. The Nasdaq Composite index and the largest fintech ETF are both ...

The S&P 500 faces a two-week stretch that could either extend the market’s impressive spring and summer rally or blunt its ...

Acquisitions in the registered investment advisory segment remain strong, despite an uncertain macroeconomic environment, a ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice. I would like to receive updates and special offers from Dow ...

Viking Therapeutics stock tumbled after the drugmaker released study results of its experimental weight-loss pill.

Evercore ISI analyst David Raso upgraded the stock to Buy from Hold. He had it at Sell at the start of the year.